Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,350
Sort by:
Italian Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Italian hospital laboratories. Instrumentation technologies and feature ...
June 2017
887 pages
Japanese Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 5,220.00
... , 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Japanese hospital laboratories. Instrumentation technologies and feature ...
June 2017
891 pages
Spanish Hospital Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,005.00
... , 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory ... on definition, epidemiology, and etiology of major infectious diseases and microorganisms. Volume and sales forecasts for 80 infectious disease tests performed in Spanish hospital laboratories. Instrumentation technologies and feature ...
June 2017
880 pages
French Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and feature comparison ...
June 2017
533 pages
German Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and feature comparison ...
June 2017
530 pages
Italian Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and feature comparison ...
June 2017
525 pages
Japanese Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 4,365.00
... , 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and feature comparison ...
June 2017
537 pages
Spanish Hospital Tumor Marker Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
US$ 3,465.00
... , 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory ... , ovarian, testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and feature comparison ...
June 2017
521 pages
Australia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Austria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Belgium Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Bulgaria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Canada Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Cyprus Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Czech Republic Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
June 2017
535 pages
Denmark Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Estonia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Finland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Greece Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Hungary Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Iceland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Ireland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Latvia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Lithuania Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Malta Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Netherlands Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Norway Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Poland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Romania Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Slovakia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Slovenia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Sweden Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Switzerland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor ...
June 2017
535 pages
Bangladesh Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Brazil Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Chile Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
China Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Colombia Republic Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
June 2017
535 pages
Croatia Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Egypt Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Ghana Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Hong Kong Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in ... and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
June 2017
535 pages
India Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Indonesia Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Iran Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Iraq Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
Israel Tumor Marker Testing Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... market entry barriers and risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers ...
June 2017
535 pages
